Charles V. Baltic's most recent trade in MEI Pharma Inc was a trade of 81,500 Common Stock done at an average price of $0.2 . Disclosure was reported to the exchange on Feb. 28, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| MEI Pharma Inc | Charles V. Baltic | Director | Purchase of securities on an exchange or from another person at price $ 0.23 per share. | 28 Feb 2023 | 81,500 | 105,750 (0%) | 0% | 0.2 | 18,338 | Common Stock |
| MEI Pharma Inc | Charles V. Baltic | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 87,500 | 87,500 | - | - | Stock Option (Right to Buy) | |
| MEI Pharma Inc | Charles V. Baltic | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) |